Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Authors / Elad Moisseiev and Susanna Park

Elad Moisseiev and Susanna Park

Elad Moisseiev is a vitreoretinal surgeon in the Department of Ophthalmology, Tel Aviv Medical Center, in Tel Aviv, Israel. He is a faculty member of the Sackler School of Medicine at the Tel Aviv University, and completed his ophthalmology residency training at the Tel Aviv Medical Center, and vitreoretinal surgery fellowship at the University of California Davis, Sacramento, CA, USA. Susanna Park is a Professor of Ophthalmology at the University of California Davis, Sacramento, CA, USA. She is a vitreoretinal surgeon and clinician scientist who has conducted research on bone marrow stem cell therapy for retinal disease for over ten years. The authors thank the following collaborators at the University of California Davis: Jan Nolta and Gerhard Bauer of the Institute for Regenerative Cures for the stem cell isolation, Robert Zawadzki for retinal imaging and Zeljka Smit-McBride for microarray analysis.

  • Contributions

It’s in Their Bones

March 3, 2017

Bone marrow stem cells for the treatment of retinal disease? They’re closer to the clinic than you might think

1 min read

It’s in Their Bones

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: